Sarah Cannon Cancer Center at Parkridge Medical Center — Chattanooga, Tennessee

Sarah Cannon Cancer Center at Parkridge Medical Center is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Cancer Center at Parkridge Medical Center has participated in 2 clinical trials.

Therapeutic areas: Lung Cancer, Colorectal Cancer.

Sponsors: Radiation Therapy Oncology Group, Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Cancer Center at Parkridge Medical Center?

Sarah Cannon Cancer Center at Parkridge Medical Center has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Cancer Center at Parkridge Medical Center conducted?

Sarah Cannon Cancer Center at Parkridge Medical Center has 2 clinical trials on record. Their work covers Lung Cancer, Colorectal Cancer.

Is Sarah Cannon Cancer Center at Parkridge Medical Center accredited by Crixeo Clinical Trials?

Sarah Cannon Cancer Center at Parkridge Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Cancer Center at Parkridge Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.